+39 339 659 6105 info@hepbcppa.org

Menu
Finance & Transparency

Sponsorship 2009-2015 Hepatitis B&C Public Policy Association asbl


SPONSOR AMOUNT EUROSACTIVITIES
2009/2010
Gilead Sciences Europe Ltd 428,987.00 Set-up & 2010 Summit
Janssen Pharmaceuticals NV 140,000.00 Set-up & 2010 Summit
GlaxoSmithKline Biologicals SA 30,000.00 2010 Summit
Bristol Myers Squibb EMEA SARL 50,000.00 2010 Summit
Schering-Plough 175,000.00 2010 Summit
2011/2012
Gilead Sciences Europe Ltd 250,000.00 Unrestricted & 2012 Summit
Janssen Pharmaceuticals NV 75,000.00 Educational grant
Bristol Myers Squibb EMEA SARL 35,000.00 2011/2012activities & 2012 summit
Gilead Sciences Hellas M.EPE 15,000.00 2011 Call to action
2013/2014
Bristol Myers Squibb EMEA SARL 45,000.00 2013 Activities & Summit 2014
Merck Sharp and Dohme 20,000.00 2012 Conference
Gilead Sciences Europe LTD 203,000.00 2013 Activities & Summit 2014
Gilead Sciences Hellas M.EPE 18,000.00 Summit 2014
Abbvie Pharma S.A. Greece 70,000.00 Summit 2014 & 2014 activities
Bristol Myers Squibb EMEA SARL 45,000.00 2014 Summit & activities
2015/2016
Gilead Sciences Europe Ltd 180,000.00 Core funding 2015
Abbvie Pharmaceuticals France 130,000.00 2016 EU Policy Summit